Although our study findings suggested that immunohistochemical positivity for BCL2 and BCL6 should be independently associated with a short PFS rather than OS in a multivariate analysis, controversy persists regarding the role of BCL2 and BCL6 protein expression on the prognosis of PCNSL patients. This evidence concerns the gene BCL2 and primary central nervous system lymphoma.